Results 231 to 240 of about 509,395 (261)
Some of the next articles are maybe not open access.
FDA Approval of Remdesivir — A Step in the Right Direction
New England Journal of Medicine, 2020Kirk M Chan-Tack +2 more
exaly
Cancer Risk Associated With Lorcaserin — The FDA’s Review of the CAMELLIA-TIMI 61 Trial
New England Journal of Medicine, 2020Christian Hampp, Eugenio Andraca-Carrera
exaly
Modernizing the FDA’s 510(k) Pathway
New England Journal of Medicine, 2019Joseph S. Ross, Vinay K Rathi
exaly
Regulating Off-Label Drug Use — Rethinking the Role of the FDA
New England Journal of Medicine, 2008Randall S. Stafford
exaly
Anesthesia and Developing Brains — Implications of the FDA Warning
New England Journal of Medicine, 2017Michael F Greene, Dean B Andropoulos
exaly
The FDA, E-Cigarettes, and the Demise of Combusted Tobacco
New England Journal of Medicine, 2014David B Abrams, Nathan K Cobb
exaly

